ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2
- Memorial Sloan Kettering Cancer Center, United States
- Weill Cornell Medicine, United States
- Cited 5
- Views 1,194
- Annotations
Abstract
Mechanisms regulating mammalian meiotic progression are poorly understood. Here we identify mouse YTHDC2 as a critical component. A screen yielded a sterile mutant, 'ketu', caused by a Ythdc2 missense mutation. Mutant germ cells enter meiosis but proceed prematurely to aberrant metaphase and apoptosis, and display defects in transitioning from spermatogonial to meiotic gene expression programs. ketu phenocopies mutants lacking MEIOC, a YTHDC2 partner. Consistent with roles in post-transcriptional regulation, YTHDC2 is cytoplasmic, has 3′→5′ RNA helicase activity in vitro, and has similarity within its YTH domain to an N6-methyladenosine recognition pocket. Orthologs are present throughout metazoans, but are diverged in nematodes and, more dramatically, Drosophilidae, where Bgcn is descended from a Ythdc2 gene duplication. We also uncover similarity between MEIOC and Bam, a Bgcn partner unique to schizophoran flies. We propose that regulation of gene expression by YTHDC2-MEIOC is an evolutionarily ancient strategy for controlling the germline transition into meiosis.
Article and author information
Author details
Christopher D Lima
Scott Keeney
Funding
Howard Hughes Medical Institute
- M Rhyan Puno
- Christopher D Lima
- Scott Keeney
National Aeronautics and Space Administration (NNX14AH50G 15-15Omni2-0063)
- Cem Meydan
- Christopher E Mason
Bill and Melinda Gates Foundation (OPP1151054)
- Cem Meydan
- Christopher E Mason
Cycle for Survival
- Nathalie Lailler
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
- Nathalie Lailler
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37 HD035455)
- Kathryn V Anderson
Human Frontier Science Program
- Devanshi Jain
National Cancer Institute (P30 CA008748)
- Nathalie Lailler
National Institute of General Medical Sciences (R35 GM118080)
- M Rhyan Puno
- Christopher D Lima
Starr Cancer Consortium (I9-A9-071)
- Cem Meydan
- Christopher E Mason
Bert L and N Kuggie Vallee Foundation
- Cem Meydan
- Christopher E Mason
WorldQuant Foundation
- Cem Meydan
- Christopher E Mason
Pershing Square Sohn Cancer Research Alliance
- Cem Meydan
- Christopher E Mason
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All experiments conformed to regulatory standards and were approved by the Memorial Sloan Kettering Cancer Center (MSKCC) Institutional Animal Care and Use Committee under protocol #01-03-007.
Reviewing Editor
- Bernard de Massy, Reviewing Editor, Institute of Human Genetics, CNRS UPR 1142, France
Publication history
- Received: August 1, 2017
- Accepted: January 22, 2018
- Accepted Manuscript published: January 23, 2018 (version 1)
- Version of Record published: March 1, 2018 (version 2)
Copyright
© 2018, Jain et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,194
- Page views
-
- 280
- Downloads
-
- 5
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.
Download links
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
Further reading
-
- Chromosomes and Gene Expression
- Computational and Systems Biology
-
- Chromosomes and Gene Expression
- Developmental Biology
- Stem Cells and Regenerative Medicine
